Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world.
  • Posted by Rachel Howard
  • December 14, 2016
  • Blogs

A bitter pill?

A bitter pill?

The ideal route of admin isn’t clear cut in the global marketplace

A key feature of any pharmaceutical product is its route of administration; the path through which the drug is taken into the body.  This may be oral, injectable, transdermal or inhaled.  Differences in route of admin can be critical points of differentiation for new pharmaceutical products, especially in crowded markets where multiple options are available.  When conducting interviews with healthcare professionals, we commonly find that route of admin is often one of the first features they take into account (after efficacy and safety) when reviewing product profiles, and getting it right is fundamental to a product’s eventual uptake and market share.  However the perceived benefits and drawbacks of different routes of administration can be more complicated than one might think. Market nuances can have far-reaching implications for drug formulation and device design.

read more »